3. At all times relevant, the Respondent was employed by Hospital A? in Baltimore,
Maryland, as a Respiratory Therapist.

4. The Respondent was employed at Hospital A from July 12, 2010 through May 5,
2016, when Hospital A terminated her employment for reasons set forth below.

5. On or about May 16, 2016, Hospital A filed a Mandated 10-Day Report (the
“Report’) with the Board notifying the Board the Respondent's employment had been
terminated based on her diversion of intravenous (‘IV") fentanyl, a Schedule Il
controlled dangerous substance ("CDS"), from a patient's IV bag.

6. After receiving notification of the Report, the Board initiated an investigation into
the allegations.

7. The Board's investigation into the complaint as set forth below included issuing
subpoenas to obtain the Respondent's personnel and fitness for duty files from Hospital
A, obtaining treatment records, and conducting interviews of Hospital A's staff and the
Respondent. .

8. On or about July 6, 2016, the Board notified the Respondent of its investigation
and requested a response.

9. On or about July 18, 2016, the Respondent submitted a written response to the
Board, acknowledging that at 5:30 a.m. on April 23, 2016, after making patient rounds,
while in the restroom at Hospital A, she injected fentanyl into her thigh, and “passed

out,” subsequently vomiting.. A co-worker (“Employee A") located the Respondent in

2 In order to maintain confidentiality, facility, patient and employee names will not be used in this
document, but will be provided to the Respondent on request.
3
